| Effectiveness of the MF59‐adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta‐analysis BL Coleman, R Sanderson, MDM Haag, I McGovern Influenza and other respiratory viruses 15 (6), 813-823, 2021 | 90 | 2021 |
| Global patterns of seasonal influenza activity, duration of activity and virus (sub) type circulation from 2010 to 2020 P Zanobini, G Bonaccorsi, C Lorini, M Haag, I McGovern, J Paget, S Caini Influenza and Other Respiratory Viruses 16 (4), 696-706, 2022 | 39 | 2022 |
| Cell-based manufacturing technology increases antigenic match of influenza vaccine and results in improved effectiveness S Rockman, K Laurie, C Ong, S Rajaram, I McGovern, V Tran, ... Vaccines 11 (1), 52, 2022 | 27 | 2022 |
| Influenza Vaccine Uptake in the United States before and during the COVID-19 Pandemic I McGovern, A Bogdanov, K Cappell, S Whipple, M Haag Vaccines 10 (10), 1610, 2022 | 21 | 2022 |
| Review of analyses estimating relative vaccine effectiveness of cell-based quadrivalent influenza vaccine in three consecutive US influenza seasons C Boikos, I McGovern, D Molrine, JR Ortiz, J Puig-Barberà, M Haag Vaccines 10 (6), 896, 2022 | 18 | 2022 |
| Effectiveness of cell-based quadrivalent seasonal influenza vaccine: a systematic review and meta-analysis BL Coleman, I Gutmanis, I McGovern, M Haag Vaccines 11 (10), 1607, 2023 | 13 | 2023 |
| Influenza during the 2010–2020 decade in the United States: seasonal outbreaks and vaccine interventions RE Malosh, I McGovern, AS Monto Clinical Infectious Diseases 76 (3), 540-549, 2023 | 11 | 2023 |
| Investigating confounding in network‐based test‐negative design influenza vaccine effectiveness studies—Experience from the DRIVE project AL Stuurman, M Levi, P Beutels, H Bricout, A Descamps, G Dos Santos, ... Influenza and Other Respiratory Viruses 17 (1), e13087, 2023 | 11 | 2023 |
| Global analysis of respiratory viral circulation and timing of epidemics in the pre–COVID-19 and COVID-19 pandemic eras, based on data from the Global Influenza Surveillance … M Del Riccio, S Caini, G Bonaccorsi, C Lorini, J Paget, K van der Velden, ... International Journal of Infectious Diseases 144, 107052, 2024 | 10 | 2024 |
| Superior Effectiveness of Cell-Based Versus Egg-Based Quadrivalent Influenza Vaccines Against Outpatient Test-Confirmed Influenza Over Three Consecutive Seasons in the United … AN Stein, C Mills, I McGovern, A Dean, A Bogdanov, S Sullivan, M Haag Proceedings of the 9th ESWI Influenza Conference, 2023 | 9 | 2023 |
| Relative vaccine effectiveness of adjuvanted trivalent influenza vaccine over three consecutive influenza seasons in the United States C Boikos, I McGovern, JR Ortiz, J Puig-Barberà, E Versage, M Haag Vaccines 10 (9), 1456, 2022 | 8 | 2022 |
| Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved Effectiveness. Vaccines. 2023; 11 (1): 52 S Rockman, K Laurie, C Ong, S Rajaram, I McGovern, V Tran, ... | 8 | |
| Cost-effectiveness analysis of cell versus egg-based seasonal influenza vaccination in children and adults in Argentina A Urueña, P Micone, MC Magneres, I McGovern, J Mould-Quevedo, ... Vaccines 10 (10), 1627, 2022 | 7 | 2022 |
| Co-Administration of Influenza and COVID-19 Vaccines: Policy Review and Vaccination Coverage Trends in the European Union, UK, US, and Canada between 2019 and 2023 RCA Achterbergh, I McGovern, M Haag Vaccines 12 (2), 216, 2024 | 6 | 2024 |
| Epidemiology and Burden of Influenza in Children 0–14 Years Over Ten Consecutive Seasons in Italy E Barbieri, G Porcu, D Donà, S Cavagnis, L Cantarutti, A Scamarcia, ... The Pediatric Infectious Disease Journal 42 (12), e440-e446, 2023 | 4 | 2023 |
| Relative vaccine effectiveness of MF59-adjuvanted vs high-dose trivalent inactivated influenza vaccines for prevention of test-confirmed influenza hospitalizations during the … I McGovern, B Chastek, T Bancroft, N Webb, M Imran, SI Pelton, ... International Journal of Infectious Diseases 146, 107160, 2024 | 3 | 2024 |
| Influenza burden averted with a cell-based quadrivalent seasonal influenza vaccine compared with egg-based quadrivalent seasonal influenza vaccine I McGovern, A Taylor, A Sardesai, H Toro-Diaz, M Haag Expert Review of Vaccines 23 (1), 371-379, 2024 | 2 | 2024 |
| Relative Vaccine Effectiveness of Cell-vs Egg-Based Quadrivalent Influenza Vaccine Against Test-Confirmed Influenza Over 3 Seasons Between 2017 and 2020 in the United States AN Stein, CW Mills, I McGovern, KW McDermott, A Dean, AN Bogdanov, ... Open Forum Infectious Diseases 11 (5), ofae175, 2024 | 2 | 2024 |
| Incidence of Influenza-related Medical Encounters and the Associated Healthcare Resource Use and Complications Across Adult Age Groups in the United States During the 2015–2020 … I McGovern, K Cappell, AN Bogdanov, MDM Haag Clinical Infectious Diseases, ciae180, 2024 | 2 | 2024 |
| Additional Burden Averted in the United States From Use of MF59-Adjuvanted Seasonal Influenza Vaccine Compared With Standard Seasonal Influenza Vaccine Among Adults≥ 65 Years I McGovern, A Sardesai, A Taylor, H Toro-Diaz, M Haag Open Forum Infectious Diseases 10 (8), ofad429, 2023 | 2 | 2023 |
